| _version_ | 1866901077149876224 |
|---|---|
| author | V |
| author_facet | V |
| contents | <p><strong>Novel Macromolecular Targeted Chemoprotective Preparation</strong><br>This breakthrough macromolecular agent is engineered for systemic protection and efficacy enhancement during solid tumor chemotherapy.<br> Versatile Delivery: Supports oral administration (crosses the gastrointestinal barrier, bypassing hepatic first-pass degradation), IV, and subcutaneous injection.<br> Clinical Indications: Specifically antagonizes chemotherapy-induced toxicities in parenchymal organs (cardiac, hepatorenal, auditory), repairs the blood-brain barrier to alleviate neuropathy, and arrests bone marrow senescence to mitigate severe suppression.<br> Dual Mechanism: * Healthy Tissue Shield: Provides spatial isolation and neutralizes free radicals to protect normal cells.<br> - Microenvironment Remodeling: Inhibits cancer stem cell metabolism and lifts immunosuppression without compromising chemotherapeutic lethality.<br> Core Advantages: Features high specificity with minimal off-target rates and stable pharmacokinetics. The molecular conformation is robust, supporting high-temperature sterilization and long-term cold-chain storage with excellent multi-drug compatibility.<br>Currently seeking co-development with pharmaceutical companies.<br>E-mail: research@laplacedemon-lab.com</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19213671 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | UHS Chemotherapy Adjuvant V Chemotherapy <p><strong>Novel Macromolecular Targeted Chemoprotective Preparation</strong><br>This breakthrough macromolecular agent is engineered for systemic protection and efficacy enhancement during solid tumor chemotherapy.<br> Versatile Delivery: Supports oral administration (crosses the gastrointestinal barrier, bypassing hepatic first-pass degradation), IV, and subcutaneous injection.<br> Clinical Indications: Specifically antagonizes chemotherapy-induced toxicities in parenchymal organs (cardiac, hepatorenal, auditory), repairs the blood-brain barrier to alleviate neuropathy, and arrests bone marrow senescence to mitigate severe suppression.<br> Dual Mechanism: * Healthy Tissue Shield: Provides spatial isolation and neutralizes free radicals to protect normal cells.<br> - Microenvironment Remodeling: Inhibits cancer stem cell metabolism and lifts immunosuppression without compromising chemotherapeutic lethality.<br> Core Advantages: Features high specificity with minimal off-target rates and stable pharmacokinetics. The molecular conformation is robust, supporting high-temperature sterilization and long-term cold-chain storage with excellent multi-drug compatibility.<br>Currently seeking co-development with pharmaceutical companies.<br>E-mail: research@laplacedemon-lab.com</p> |
| title | UHS Chemotherapy Adjuvant |
| topic | Chemotherapy |
| url | https://doi.org/10.5281/zenodo.19213671 |